Insider trades

Carl L. Gordon, Director of ADARx Pharmaceuticals ADRX, has filed 37 purchases and 10 sales on the open market. Over the past 12 months that comes to a net purchase of $36.1M. The latest trade was on 09/28.

Carl L. Gordon

Director
First filing
23/02/09
Trades
152 trades
Buys / sales
37 / 10
12-month net buying
$36.1M
Last trade
09/28

Trading activity

Transactions

Trade type
ADRX
Open-market buy09/2809/30950,000 sh3 trades$17.00avg.$16,150,000No record
ETRA
Open-market buy09/2109/231,333,333 sh2 trades$15.00avg.$19,999,995+313.8%
Open-market sale25/04/0925/04/113,571,428 sh$1.59$5,678,570.52−100.0%
MBX
Open-market buy25/02/14–25/02/1825/02/19190,672 sh4 trades$10.60avg.$2,020,755.6+34.2%
MBX
Open-market buy24/09/1624/09/17750,000 sh2 trades$16.00avg.$12,000,000No record
KROS
Open-market sale24/08/1324/08/15250,000 sh2 trades$44.01avg.$11,002,500−67.7%
Open-market sale10b5-1 plan24/07/15–24/07/1624/07/1756,164 sh6 trades$10.00avg.$561,640−6.9%
Open-market sale24/05/1524/05/2024,344 sh$0.38$9,250.72−0.2%
AVBP
Open-market buy24/01/3024/01/31444,444 sh2 trades$18.00avg.$7,999,992+41.6%
ACET
Open-market buy24/01/2524/01/263,125,000 sh3 trades$2.40avg.$7,500,000No record
Open-market buy23/07/1723/07/19479,932 sh2 trades$3.05avg.$1,463,792.6+281.2%
ACET
Open-market buy23/06/2723/06/29875,000 sh4 trades$2.09avg.$1,828,750No record
Open-market buy23/05/04–23/05/0523/05/081,460,932 sh5 trades$2.80avg.$4,086,234.61No record
Open-market buy23/04/28–23/05/0223/05/021,405,168 sh9 trades$2.61avg.$3,673,900.83No record
Open-market buy23/02/2723/03/17348,000 sh$0.25$87,000+12.4%